We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.39B
AUM Growth
+$118M
Cap. Flow
-$190M
Cap. Flow %
-4.31%
Top 10 Hldgs %
15.83%
Holding
1,464
New
104
Increased
519
Reduced
644
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 15.67%
2 Healthcare 11.79%
3 Financials 11.13%
4 Industrials 8.9%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPL
1301
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$73.5K ﹤0.01%
12,153
+91
+0.8% +$542
XAIR icon
1302
Beyond Air
XAIR
$3.8M
$71.4K ﹤0.01%
+28
New +$71.6K
VLDR
1303
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$67K ﹤0.01%
90,722
-10,514
-10% -$9.94K
GOEV
1304
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$65.8K ﹤0.01%
116
+59
+104% +$36.2K
QS icon
1305
QuantumScape Corp
QS
$3.86B
$63K ﹤0.01%
11,104
-340
-3% -$2.52K
VVR icon
1306
Invesco Senior Income Trust
VVR
$459M
$61.3K ﹤0.01%
+16,000
New +$60.9K
OPTU
1307
Optimum Communications Inc
OPTU
$310M
$60.7K ﹤0.01%
13,200
-1,000
-7% -$4.91K
PPT
1308
Franklin Premier Income Trust
PPT
$329M
$60.3K ﹤0.01%
16,600
-2,000
-11% -$7.27K
FAX
1309
abrdn Asia-Pacific Income Fund
FAX
$603M
$57.9K ﹤0.01%
3,667
+667
+22% +$10K
BNGO icon
1310
Bionano Genomics
BNGO
$13.2M
$55.1K ﹤0.01%
63
-2
-3% -$2.52K
EAF icon
1311
GrafTech
EAF
$202M
$54.3K ﹤0.01%
1,140
-100
-8% -$4.86K
FUBO icon
1312
FuboTV Inc
FUBO
$283M
$53.4K ﹤0.01%
2,560
+325
+15% +$11.9K
UXIN
1313
Uxin Ltd
UXIN
$260M
$50.9K ﹤0.01%
1,767
NAGE
1314
Niagen Bioscience
NAGE
$242M
$50.6K ﹤0.01%
30,100
-100
-0.3% -$159
JMIA
1315
Jumia Technologies
JMIA
$734M
$48K ﹤0.01%
14,943
+1,024
+7% +$4.62K
AKTS
1316
DELISTED
Akoustis Technologies Inc
AKTS
$46.6K ﹤0.01%
16,525
-300
-2% -$943
AMRS
1317
DELISTED
Amyris Inc.
AMRS
$45.5K ﹤0.01%
29,722
-2,100
-7% -$4.69K
DHY
1318
Credit Suisse High Yield Credit Fund
DHY
$242M
$44.4K ﹤0.01%
+25,250
New +$46.3K
SPCE icon
1319
Virgin Galactic
SPCE
$495M
$42.6K ﹤0.01%
612
+68
+13% +$6.34K
SIEN
1320
DELISTED
Sientra, Inc.
SIEN
$41.4K ﹤0.01%
20,381
MBIO icon
1321
Mustang Bio
MBIO
$4.58M
$41.1K ﹤0.01%
139
-22
-14% -$7.51K
GEG icon
1322
Great Elm Group
GEG
$67.7M
$40.7K ﹤0.01%
20,164
-346
-2% -$693
RIOT icon
1323
Riot Platforms
RIOT
$7.61B
$37.9K ﹤0.01%
11,189
-6,979
-38% -$36K
TCRR
1324
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$37.9K ﹤0.01%
37,950
-1,000
-3% -$1.35K
EQRX
1325
DELISTED
EQRx, Inc. Common Stock
EQRX
$36.9K ﹤0.01%
15,000
-83,000
-85% -$327K

Similar funds

Oppenheimer & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Oppenheimer & Co held 1,464 positions worth $4.39B, up 2.8% from $4.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oppenheimer & Co withdrew a net $190M in Q4 2022, closing 116 positions and reducing 644 holdings. Its most notable exit was State Street SPDR Portfolio Mortgage Backed Bond ETF, an estimated $8.22M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in State Street SPDR Portfolio S&P 500 Value ETF worth $5.18M.

  • Oppenheimer & Co's largest Q4 2022 buy was State Street SPDR Portfolio S&P 500 Value ETF: 133,272 shares worth $5.18M.
  • Oppenheimer & Co added most to iShares Treasury Floating Rate Bond ETF in Q4 2022, an estimated $5.9M increase.
  • Oppenheimer & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $22.8M.
  • Oppenheimer & Co fully exited State Street SPDR Portfolio Mortgage Backed Bond ETF in Q4 2022, selling an estimated $8.22M.
  • Oppenheimer & Co's ten largest holdings make up 16% of its $4.39B portfolio in Q4 2022.
  • Oppenheimer & Co opened 104 new positions and closed 116 in Q4 2022.
  • Oppenheimer & Co's portfolio value rose 2.8% quarter-over-quarter to $4.39B.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.